Transplantation of Bone Marrow Mesenchymal Stromal Cells for Periodontal Regeneration
NCT05975892 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2023-08-04
Summary
The goal of this study is to evaluate the capacity of allogeneic bone marrow mesenchymal stromal cells (MSC) to induce bone regeneration in patients with periodontal disease. MSC cultured are loaded on a collagen scaffold, included into autologous platelet rich plasma clot and implanted in the bone defect.
Conditions
- Chronic Periodontal Disease
- Aggressive Periodontitis
Interventions
- BIOLOGICAL
-
Transplantation of allogeneic MSCs in periodontal disease
Oral surgery is performed in patients with periodontal disease, under local anesthesia. An incision will be made on the periodontal lesion, A full-thickness flap is elevated on both the buccal and lingual areas and the inner epithelium of the flap removed. Granulation tissue is removed from bone defect area, and a root planning is performed. MSC construct is placed around the bone defect and a collagen membrane is used to cover and close off the bone defect site. The flap will be repositioned and the wound closed by a suture
Sponsors & Collaborators
-
Universidad Central de Venezuela
collaborator OTHER -
Hospital Central Dr. Plácido D. Rodriguez Rivero, San Felipe, Yaracuy
collaborator UNKNOWN -
Instituto Venezolano de Investigaciones Cientificas
lead OTHER
Principal Investigators
-
Jose E Cardier Montalvo, MD, PhD · Instituto Venezolano de Investigaciones Cientificas
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-08-30
- Primary Completion
- 2022-08-30
- Completion
- 2024-08-30
Countries
- Venezuela
More Related Trials
-
Treatment of Patients With Bone Tissue Defects Using Mesenchymal Stem Cells Enriched by Extracellular Vesicles
NCT05520125 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety and Tolerance of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Ankylosing Spondylitis
NCT05962762 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Autologous Bone Marrow Stem Cells in Pressure Ulcer Treatment
NCT01572376 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Bone Marrow Mononuclear Cells vs Mesenchymal Stem Cells in Diabetic Patients With Chronic Limb Ischemia
NCT05631444 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate Allogenic Bone-Marrow Mesenchymal Stromal Cell Product StromaForte in Aging Frailty Patients
NCT06063590 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Stem Cell Therapy for Type 2 Diabetes Mellitus
NCT01142050 ·Status: UNKNOWN ·Phase: PHASE1
-
A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD
NCT06321198 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells
NCT05705024 ·Status: RECRUITING ·Phase: PHASE2
-
Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease
NCT05362786 ·Status: COMPLETED ·Phase: PHASE1
-
MSC Therapy in Liver Transplantation
NCT02260375 ·Status: RECRUITING ·Phase: PHASE1
-
Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema
NCT01849159 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Hypoxia and Inflammatory Injury in Human Renovascular Hypertension
NCT02266394 ·Status: COMPLETED ·Phase: PHASE1
-
MSC and MC in Type 2 Diabetes Mellitus
NCT01719640 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Stem Cell Therapy for Chronic Kidney Disease
NCT04869761 ·Status: COMPLETED ·Phase: PHASE1
-
MSC for Occlusive Disease of the Kidney
NCT01840540 ·Status: COMPLETED ·Phase: PHASE1
-
Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With Malignancies
NCT02804945 ·Status: COMPLETED ·Phase: PHASE1
-
Stem Cell Therapy for Type 1 Diabetes Mellitus
NCT01143168 ·Status: UNKNOWN ·Phase: PHASE1
-
A Clinical Study Using Autologous Bone Marrow Stem Cell for Diabetes Related Vascular Complications
NCT02796079 ·Status: UNKNOWN ·Phase: PHASE1
-
MSC and Kidney Transplant Tolerance (Phase A)
NCT02565459 ·Status: UNKNOWN ·Phase: PHASE1
-
Autologous Bone Marrow Stem Cell Transplantation in Patients With Subacute Spinal Cord Injury
NCT05671796 ·Status: UNKNOWN ·Phase: PHASE2
-
Umbilical Cord Derived Mesenchymal Stromal Cells For The Treatment of Severe Steroid-resistant Graft Versus Host Disease
NCT02032446 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Mesenchymal Stem Cells as First Treatment Line for Resistant Acute Graft Versus Host Disease
NCT02770430 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip
NCT02065167 ·Status: COMPLETED ·Phase: PHASE2
-
Mesenchymal Stem Cells in Osteonecrosis of the Femoral Head
NCT01605383 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells
NCT01700920 ·Status: COMPLETED ·Phase: PHASE2